Weidong D. Han

No. 28 Fuxing Road
Beijing, 100853, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 125 publications

Reduced YTHDF2 inhibits PD-L1 expression by stabilizing m6A-containing SPOP mRNA in colorectal cancer.

Reduced YTHDF2 inhibits PD-L1 expression by stabilizing m6A-containing SPOP mRNA in colorectal cancer.

Journal: Cell death & disease

Published: October 06, 2025

The role of SMARCA4 in lung cancer.

The role of SMARCA4 in lung cancer.

Journal: Scientific reports

Published: March 03, 2025

Concomitant Medications Alter Clinical Outcomes in Patients with Advanced Digestive Tract Cancer Receiving PD-1 Checkpoint Inhibitors Combined with Antiangiogenetic Agents.

Concomitant Medications Alter Clinical Outcomes in Patients with Advanced Digestive Tract Cancer Receiving PD-1 Checkpoint Inhibitors Combined with Antiangiogenetic Agents.

Journal: Journal of gastrointestinal cancer

Published: July 20, 2024

TRIM59 deficiency promotes M1 macrophage activation and inhibits colorectal cancer through the STAT1 signaling pathway.

TRIM59 deficiency promotes M1 macrophage activation and inhibits colorectal cancer through the STAT1 signaling pathway.

Journal: Scientific reports

Published: May 07, 2024

BPI-28592 as a novel second generation inhibitor for NTRK fusion tumors.

BPI-28592 as a novel second generation inhibitor for NTRK fusion tumors.

Journal: NPJ precision oncology

Published: April 04, 2024

Association of frailty with mortality in cancer survivors: results from NHANES 1999-2018.

Association of frailty with mortality in cancer survivors: results from NHANES 1999-2018.

Journal: Scientific reports

Published: February 20, 2023

The benefit of anti-angiogenic therapy in EGFR exon 21 L858R mutant non-small cell lung cancer patients: a retrospective study.

The benefit of anti-angiogenic therapy in EGFR exon 21 L858R mutant non-small cell lung cancer patients: a retrospective study.

Journal: Scientific reports

Published: May 21, 2022

Programmed cell death-1 inhibitor combination treatment for recurrent proficient mismatch repair/ miscrosatellite-stable type endometrial cancer: A case report.

Programmed cell death-1 inhibitor combination treatment for recurrent proficient mismatch repair/ miscrosatellite-stable type endometrial cancer: A case report.

Journal: World journal of clinical cases

Published: November 27, 2021

An esterase-activatable prodrug formulated liposome strategy: potentiating the anticancer therapeutic efficacy and drug safety.

An esterase-activatable prodrug formulated liposome strategy: potentiating the anticancer therapeutic efficacy and drug safety.

Journal: Nanoscale advances

Published: November 27, 2021

Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial.

Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial.

Journal: Stem cell research & therapy

Published: November 24, 2021

Structural optimization and prospect of chimeric antigen receptor T cells

Structural optimization and prospect of chimeric antigen receptor T cells

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: November 09, 2021

B3galt5 deficiency attenuates hepatocellular carcinoma by suppressing mTOR/p70s6k-mediated glycolysis.

B3galt5 deficiency attenuates hepatocellular carcinoma by suppressing mTOR/p70s6k-mediated glycolysis.

Journal: Cellular and molecular life sciences : CMLS

Published: November 02, 2021

Showing 1-12 of 125

Last Updated: 09/26/2026